Retina Update Meeting 2024
Naples, May 25th, 2024
A brand-new dedicated website is on its way
Retina update meeting 2023
February 3rd, 2023
Istituto Veneto di Scienze Lettere ed Arti Palazzo Cavalli Franchetti – VENICE
Presidents of the meeting
With the Patronage of
Dipartimento di Neuroscienze – DNS
Università degli Studi di Padova
Università degli Studi di Milano
Introduction
Dear Colleagues,
As we all know, the field of retina is rapidly changing with new innovations in retinal diagnostics, therapeutics and our understanding of retinal disease pathophysiology.
The objective of this Retina update meeting is to provide a comprehensive overview of these new directions in our field, which all of us as ophthalmologists caring for patients with retinal disease must be aware of.
To achieve this goal, we are bringing together a group of renowned clinicians and scientists from around the world to share their collective expertise with us.
We will address the breadth of retinal diseases including age-related macular degeneration, retinal vascular diseases, and inherited retinal degenerations.
We will focus on new disease mechanisms, novel diagnostics, and emerging therapeutics. We will also include time for discussion and engagement with the experts, as we all learn to gather.
We hope that you will join us in the fabulous city of Venice for this meeting.
Sincerely,
Edoardo Midena, SriniVas Sadda, Giovanni Staurenghi
Preliminary program
08:00 a.m. – 09:20 a.m. Session 1: Inherited Retinal Dystrophies
Moderators: Moderators: B. Falsini, J. Sparrow
08:00 a.m. – 08:10 a.m. Gene therapy: the different possibility
A.P. Salvetti
08:10 a.m. – 08:25 a.m. Imaging of Recessive Stargardt
J. Sparrow
08:25 a.m. – 08:40 a.m. Voretigenene parvovec: clinicalr esults in real life
F. Testa
08:40 a.m. – 08:55 a.m. Voretigenene parvovec: atrophy isit real a side effect?
A. Sodi
08:55 a.m. – 09:20 a.m. Invited lecture
Emerging technologies for imaging cellular function and health
S. Fraser
09.20 a.m. – 12.00 p.m. Session 2: Dry Age-Related Macular Degeneration Diagnostic Innovations and Challenges
Moderators: U. Chakravarthy, S. Sadda
09:20 a.m. – 09:35 a.m. Fundus autofluorescence imaging in the clinical practice for AMD
S. Schmitz – Valckenberg
09:35 a.m. – 09:50 a.m. Near infrared photobiomodulation for intermediate AMD: a new opportunity or another dead hand?
F.Viola, M. Nassisi
09:50 a.m. – 10:05 a.m.Incomplete retinal pigment epithelial and outer retinal atrophy: longitudinal evaluation in AMD
R. Guymer
10:05 a.m. – 10:20 a.m. Emerging therapy for Geographic Atrophy: an overview
J. Mones
10:20 a.m. – 10:35 a.m. The Onset and Progression of Persistent Hypertransmission Defects in Intermediate AMD: A Novel Clinical Trial Endpoint
P. Rosenfeld
10:35 a.m. – 10:50 a.m. Hyperreflective foci: towards function-structure correlation
T. Ach
10:50 a.m. – 11:05 a.m. Agreement between DLS /SIRE on SD OCT and OCTA in detection of non exudative nAMD
U. Chakravarty
11:05 a.m. – 11:20 a.m. Pachyvitelliform Maculopathy: A New Etiology of Acquired Vitelliform Lesions
D. Sarraf
11.20 a.m. – 11.35 a.m. Rod-mediated dark adaptation and OCT angiography at the aging-AMD transition: ALSTAR2
C. Curcio
11:35 a.m. – 12.00 p.m Panel Discussion: Considerations for incorporating anti-complement therapies into our clinical practice.
Moderator: P. Rosenfeld
Panelists: K. Csaky, J. Mones, S. Schmitz-Valckenberg, G.Staurenghi
12:00 p.m. – 01:30 p.m. Session 3. Wet AMD
Moderator: D. Pauleikhoff, G. Staurenghi
12:00 p.m. – 12.15 p.m. Retinal microvascular abnormalities masquerading as neovascular AMD
B.K. Freund
12:15 p.m. – 12.30 p.m. Longterm results of anti-VEGF therapy in nAMD consequences for treatment strategies
D. Pauleikhoff
12:30 p.m. – 12.45 p.m. Management of subclinical choroidal neovascularization as determined by optical coherence tomography angiography
K. Csaky
12:45 p.m. – 01.00 p.m. Faricimab and Aflibercept 8mg for wet AMD
A. Invernizzi
01:00 p.m. – 01:15 p.m. AMD drugs in the pipelines 2023
G. Jaffe
01:15 p.m. – 01:30 p.m. Panel Discussion on Wet AMD
Moderator: S. Sadda
Panelists: F. Bottoni, T.H. Lim, G. Jaffe, A. Tufail, F. Viola
01:30 p.m. – 03:30 p.m. Session4: Diabetic retinopathy and other retinal diseases.
Moderator: E. Midena, R. Tadayoni
01:30 p.m. – 01:45 p.m. What is the role of OCTA in monitoring diabetic retinopathy?
R. Tadayoni
01:45 p.m. – 02:00 p.m. Screening for Hydroxychlorqouine Retinopathy insights from quantitative OCT analyses
C. Cukras
02:00 p.m. – 02:15 p.m. Anti-VEGF and progression to PDR: implications on follow-up
A. Tufail
02:15 p.m. – 02:30 p.m. Diabetic macular edema phenotypes: the combined imagingand omics
E. Midena
02:30 p.m. – 02:45 p.m. Pharmacologic reatment for Diabetic Macula Edema
E. Pilotto
02:45 p.m. – 03:00 p.m. ROP and new prognostic systemic parame
R. Parrozzani
03:00 p.m. – 03:15 p.m. OCT-A in Ocular oncology pro and con
M. Pellegrini
03:15 p.m. – 03:30 p.m. Closing Remarks
E. Midena, S. Sadda, G. Staurenghi
A special thank for not conditioning financial support to:
Presidents of the meeting
Edoardo Midena
Full Professor of Ophthalmology and Visual Sciences University of Padova, School of Medicine
Chairman of the Department of Ophthalmology Padova University Hospital
Padua, Italy
Giovanni Staurenghi MD, FARVO, FEBO
Professor of Ophthalmology, Chairmen Eye Clinic
Department of Biomedical and Clinical Sciences “Luigi Sacco” Luigi Sacco Hospital, University of Milan – Italy
SriniVas R. Sadda, M.D.
Director, Artificial Intelligence & Imaging Research, Doheny Eye Institute Professor of Ophthalmology
David Geffen School of Medicine
University of California – LA
Faculty list
Organizers: MIDENA EDOARDO – SADDA SRINIVAS – STAURENGHI GIOVANNI
ACH THOMAS
Department of Ophthalmology
University of Bonn, Germany
BOTTONI FERDINANDO
Eye Clinic, Department of Clinical Science “Luigi Sacco”,
Sacco Hospital, University of Milan – Milan, Italy
CHAKRAVARTHY USHA
Professor, Ophthalmology and Vision Sciences
Royal Victoria Hospital (The Belfast Trust) and Queens University of Belfast, Northern Ireland
CSAKY KARL
T. Boone Pickens Director
Clinical Center of Innovation for AMD
Chief Executive and Medical Officer
Retina Foundation of the Southwest
CUKRAS CATHERINE
Director of the Medical Retina Fellowship Program at National Eye Institute
National Intitute of Health, Bethesda, MD, USA
CURCIO CHRISTINE
White-McKee Endowed Professor of Ophthalmology and Visual Science
Director of the AMD Histopathology Laboratory
University of Alabama at Birmingham Heersink School of Medicine
Birmingham Alabama USA
FALSINI BENEDETTO
Associate Professor, Department of Ophthalmology and Otolaryngology,
Universita Cattolica del S. Cuore, Rome, Italy
FRASER SCOTT
Provost Professor of Biology and Bioengineering
Elizabeth Garrett Professor of Convergent Biosciences
Director of Science Initiatives
Director Bridge Institute University of Southern California USA
FREUND BAILEY
Vitreous Retina Macula Consultants of New York
Clinical Professor of Ophthalmology, NYU School of Medicine New York, NY
GUYMER ROBYN
Deputy Director, Centre for Eye Research Australia,
Professor Department of Surgery, (Ophthalmology)
University of Melbourne
JAFFE GLEN
Robert Machemer Professor of Ophthalmology
Chief, Vitreoretinal Division
Director, Duke Reading Center
Durham, NC
LIM TOCK HAN
Group Chairman Medical Board, National Healthcare Group, Singapore
Adj. Professor, Lee Kong Chian School of Medicine,
Nanyang Technology University, Singapore
Senior Consultant, NHG Eye Institute, Tan Tock Seng Hospital, Singapore
MONES JORDI
Director Institut de la Màcula, Centro Médico Teknon
Medical Director Barcelona Macula Foundation: Research for Vision
Barcelona, Spain
NASSISI MARCO
Consultant, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico di Milano
Ophthalmology Unit, Milan, Italy
University of Milan, Department of Clinical Sciences and Community Health,
Milan, Italy.
PARROZZANI RAFFAELE
Associate Professor of Ophthalmology, Department of Neuroscience Ophthalmology,
University of Padova, Padova Italy
PAULEIKHOFF DANIEL
Chair of the Department of Ophthalmology, St. Franziskus-Hospital Münster
Professor of Ophthalmology, University of Duisburg-Essen,
Germany
PELLEGRINI MARCO
Consultant, Eye Clinic, Department of Biomedical and Clinical Sciences, Luigi Sacco Hospital, University of Milan, Italy
PILOTTO ELISABETTA
Associate Professor of Ophthalmology, Department of Neuroscience Ophthalmology,
University of Padova, Padova Italy
ROSENFELD PHILIP
Professor of Ophthalmology
Bascom Palmer Eye Institute Miami
University of Miami Miller School of Medicine
Miami, FL, USA
SALVETTI ANNA PAOLA
Consultant of Medical Retina and Ocular Genetics
Eye Clinic, Department of Biomedical and Clinical Sciences,
Luigi Sacco Hospital,
University of Milan, Italy
SARRAF DAVID
Clinical Professor of Ophthalmology
Retinal Disorders and Ophthalmic Genetics Division
Stein Eye Institute, UCLA
SCHMITZ- VALCKENBERG STEFFEN
Jon M. Huntsman Presidential Professor
Ophthalmology & Visual Sciences
John A. Moran Eye Center – University of Utah
Salt Lake City, US
SODI ANDREA
University of Florence – Florence, Italy
SPARROW JANET
Department of Ophthalmology
Columbia University Medical Center – NY
New York, US
TADAYONI RAMIN
Chef des services d’ophtalmologie des hôpitaux universitaires Lariboisière, Saint Louis et Fernand
Widal et du service rétine de l’Hôpital Cochin, Paris.
Professor of Ophthalmology, Université de Paris 7-Sorbonne Paris Cité
TESTA FRANCESCO
School of Medicine
Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy
TUFAIL ADNAN
Consultant ophthalmologist in the Medical Retina Service at Moorfields Eye Hospital
Professor of Ophthalmology at University College London
London, UK
VIOLA FRANCESCO
Associate Professor
Department of Clinical Sciences and Community Health
University of Milan
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
Milan, Italy
General information
Meeting Venue
Your Attractive Istituto Veneto di Scienze, Lettere ed Arti – Palazzo Cavalli Franchetti Campo S. Stefano 2945 – 30124 Venezia
How to get to the meeting venue
Official language
The official language of the Meeting will be English.
CME accreditation
The application for CME accreditation has been submitted for Italian Physicians.
The CME credits will be awarded only after 90% attendance of all sessions.
Completion of the Registration Form, the Learning & Assessment questionnaires are compulsory.
Technical facilities
A Slide Centre with PCs (Windows and Macintosh operating systems) will be available for Speakers to check and preview their presentations. Speakers are kindly requested to submit
their presentations on USB flash drive to the Slide Centre technicians at least one hour before the opening of the Session.
Certificate of attendance
The attendance certificate will be provided on-site, upon request at the Registration Desk.
Congress Organizer/Provider
AVEC S.r.l. – Incentive Paintings
Via Lavoratori Autobianchi, 1 – Edificio 9 – Ufficio 14 20832 Desio (MB)
Tel. 0039 0362/581579 – Fax. 0039 0362/1860074 info@avec-eventi.com
Registration fee
• € 200 + VAT 22% = € 244
• No registration fee is required for STUDENTS AND POSTGRADUATE
Registration fee payment
Payment of fee should be made in EURO and can be paid by bank transfer to:
AVEC S.r.l.
BANCA BPM – Filiale 777 – Viale Liguria, 1 – 20093 Cologno Monzese (Milano) IBAN IT46 X 05034 32972 000000061108
C/c 61108
SWIFT CODE BAPPIT22
Registration form
Please download the registration form and return to info@avec-eventi.com